domingo, 14 de mayo de 2017

KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients. External Web Site Icon Garzón Mónica et al. Translational lung cancer research 2016 Oct 5(5) 511-516

https://phgkb.cdc.gov/GAPPKB/phgHome.do

liquid biopsy

From From Genomics & Health Impact Scan Database
This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

No hay comentarios:

Publicar un comentario